ProMIS Neurosciences Inc
Research ProMIS Neurosciences Inc (PMN) on Bullrun: market cap USD 84.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPMN
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 84.74M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 11.73M
- Free cash flow-USD 10.39M
Valuation Snapshot
latest market cap is USD 84.74M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 39.72M | -USD 28.12M | n/a | -22.61 | USD 6.12M | n/a | -USD 1.26M |
| FY2024 | USD 0 | USD 2.78M | -USD 27.18M | n/a | 2.63 | USD 13.29M | n/a | USD 16.49M |
| FY2023 | USD 0 | -USD 13.21M | -USD 10.84M | n/a | -1.07 | USD 12.60M | USD 0 | USD 3.75M |
| FY2022 | USD 0 | -USD 18.06M | -USD 17.04M | n/a | -2.41 | USD 5.88M | n/a | -USD 1.35M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 84.74M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 14.70M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 31.06M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 21.72M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 37.24M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 47.49M | n/a | n/a | n/a |
About ProMIS Neurosciences Inc
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ProMIS Neurosciences Inc's market cap?
ProMIS Neurosciences Inc's market capitalization is USD 84.74M.
What does ProMIS Neurosciences Inc do?
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing.